Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash, cash equivalents and restricted cash	$ 92.6	$ 90.8
Investments	2.8	3.0
Trade receivables, contract assets and other receivables, net of allowance for credit losses of $2.1 and $2.3, respectively	172.6	167.2
Inventories	434.9	422.7
Prepaid and refundable income taxes	4.7	9.3
Prepaid expenses and other assets	29.6	29.8
Total current assets	737.2	722.8
Property and equipment, net of accumulated depreciation of $270.3 and $264.4, respectively	180.5	181.9
Investments	19.3	18.9
Goodwill	25.1	25.0
Intangible assets, net of accumulated amortization of $56.5 and $55.3, respectively	10.5	11.2
Deferred income tax assets	46.6	45.8
Other long-term assets	36.8	38.0
Total assets	1,056.0	1,043.6
Current liabilities:
Short-term debt	11.5	13.3
Accounts payable	91.6	79.2
Customer deposits	72.3	77.3
Accrued product warranty	17.8	16.1
Accrued employee related liabilities	38.4	38.2
Accrued loss reserves	1.3	1.7
Other current liabilities	44.1	45.9
Total current liabilities	277.0	271.7
Long-term debt	96.0	105.0
Deferred income tax liabilities	2.3	2.4
Other long-term liabilities	27.6	26.9
Total liabilities	402.9	406.0
Commitments and contingencies (Note 7)
Shareholders' equity:
Preferred stock – authorized 2,000,000 shares of $1.00 par value; none issued	0.0	0.0
Common stock – authorized 40,000,000 shares of $0.20 par value; issued and outstanding – 22,840,087 as of March 31, 2025 and 22,803,976 as of December 31, 2024	4.6	4.6
Additional paid-in capital	144.0	142.9
Accumulated other comprehensive loss	(48.1)	(51.1)
Company stock held by deferred compensation programs, at cost	(0.3)	(0.3)
Retained earnings	553.0	541.7
Shareholders' equity	653.2	637.8
Noncontrolling interest	(0.1)	(0.2)
Total equity	653.1	637.6
Total liabilities and equity	$ 1,056.0	$ 1,043.6